podiatrist 发表于 2025-3-23 10:52:08

http://reply.papertrans.cn/15/1500/149983/149983_11.png

Tempor 发表于 2025-3-23 16:16:47

http://reply.papertrans.cn/15/1500/149983/149983_12.png

debacle 发表于 2025-3-23 19:03:47

Angiogenesis inhibitors: What is the clinical future?,s or classic chemotherapy, there is no longer doubt that anti-angiogenic agents have become part of anticancer therapy in general. In the coming years, we should further explore the treatment strategies in which anti-angiogenic agents will add to a prolonged survival and an increase in the cure rate

NATTY 发表于 2025-3-23 23:24:03

http://reply.papertrans.cn/15/1500/149983/149983_14.png

裁决 发表于 2025-3-24 04:15:42

https://doi.org/10.1007/3-7643-7414-4angiogenesis; antibody; apoptosis; cancer; cancer prevention; cancer therapy; cancer treatment; cell; metast

蒙太奇 发表于 2025-3-24 09:25:20

http://reply.papertrans.cn/15/1500/149983/149983_16.png

拥护 发表于 2025-3-24 11:23:59

Paul L. Herrling,Alex Matter (Director),Richard M.Excellent overview of new approaches for the treatment of cancer.Covers a large range of molecular targets.Discusses the potential for clinical application

意见一致 发表于 2025-3-24 14:52:01

Progress in Drug Researchhttp://image.papertrans.cn/a/image/149983.jpg

使虚弱 发表于 2025-3-24 19:52:22

http://reply.papertrans.cn/15/1500/149983/149983_19.png

玉米棒子 发表于 2025-3-25 00:49:41

http://reply.papertrans.cn/15/1500/149983/149983_20.png
页: 1 [2] 3 4 5
查看完整版本: Titlebook: Advances in Targeted Cancer Therapy; Paul L. Herrling,Alex Matter (Director),Richard M. Book 2005 Birkhäuser Basel 2005 angiogenesis.antib